1. Home
  2. PCT vs IMNM Comparison

PCT vs IMNM Comparison

Compare PCT & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PureCycle Technologies Inc.

PCT

PureCycle Technologies Inc.

HOLD

Current Price

$10.57

Market Cap

1.8B

Sector

Utilities

ML Signal

HOLD

Logo Immunome Inc.

IMNM

Immunome Inc.

HOLD

Current Price

$20.50

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCT
IMNM
Founded
2015
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Environmental Services
Medicinal Chemicals and Botanical Products
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.2B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
PCT
IMNM
Price
$10.57
$20.50
Analyst Decision
Buy
Strong Buy
Analyst Count
3
9
Target Price
$13.67
$31.44
AVG Volume (30 Days)
4.2M
3.5M
Earning Date
02-26-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,660,000.00
$9,679,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$723.85
$11.53
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.40
$5.15
52 Week High
$17.37
$25.30

Technical Indicators

Market Signals
Indicator
PCT
IMNM
Relative Strength Index (RSI) 62.98 51.08
Support Level $9.88 $19.60
Resistance Level $10.75 $22.01
Average True Range (ATR) 0.51 1.09
MACD 0.22 -0.22
Stochastic Oscillator 93.78 38.16

Price Performance

Historical Comparison
PCT
IMNM

About PCT PureCycle Technologies Inc.

PureCycle Technologies Inc is a Florida-based corporation focused on commercializing a patented dissolution process to physically separate the polymer from other plastics, color, and contaminants (the Technology), originally developed by The Procter & Gamble Company (P&G), for restoring waste polypropylene into resin with near-virgin characteristics, called PureFive resin. PureFive resin represents the family of recycled resin products produced, including ultra-pure resin and other grades used for compounding to meet customer specifications, which has similar properties and applicability for reuse as virgin polypropylene. It has a single operating segment, which encompasses integrated business activities related to the recycling of polypropylene into resins.

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

Share on Social Networks: